What is the appropriate dosing regimen of Minipress (prazosin) for hypertension?

Minipress Dosing for Hypertension

Start with 1 mg two to three times daily, then slowly titrate to a maintenance dose of 6-15 mg daily in divided doses, with a maximum of 40 mg daily if needed, though prazosin is no longer a first-line agent for hypertension. 1

Critical First-Dose Warning

The initial dose must be 1 mg to minimize the risk of syncope, which occurs in approximately 1% of patients given 2 mg or more as a first dose. 1 Syncopal episodes typically occur within 30-90 minutes of the initial dose due to excessive postural hypotension, occasionally preceded by severe tachycardia (120-160 bpm). 1 Never use the 2 mg or 5 mg capsules for initial therapy. 1

Dosing Algorithm

Initial Phase

• Start: 1 mg two or three times daily 1
• Monitor: First dose should be given with caution; warn patients about dizziness, lightheadedness, and potential syncope 1
• Advise: Patients should avoid situations where injury could occur if syncope develops during initiation 1

Titration Phase

• Increase slowly to achieve blood pressure control
• Typical maintenance range: 6-15 mg daily in divided doses 1
• Maximum effective dose: 20 mg daily (doses above this rarely increase efficacy) 1
• Absolute maximum: 40 mg daily in divided doses for select patients who may benefit 1

Maintenance Considerations

• After initial titration, some patients can be maintained on twice-daily dosing 1
• Research shows mean effective doses of 5.6 mg daily for monotherapy and 10 mg daily for combination therapy 2

Combination Therapy Adjustments

When adding a diuretic or other antihypertensive agent:

• Reduce prazosin to 1-2 mg three times daily 1
• Retitrate carefully from this lower dose 1

Important drug interaction: Concomitant PDE-5 inhibitors cause additive blood pressure lowering and symptomatic hypotension; initiate PDE-5 inhibitors at the lowest dose in patients taking prazosin. 1

Why Prazosin Is Not First-Line

Modern hypertension guidelines do not recommend prazosin as a first-line agent. The 2025 AHA/ACC and 2024 ESC guidelines clearly establish that ACE inhibitors, ARBs, dihydropyridine calcium channel blockers, and thiazide/thiazide-like diuretics are the recommended first-line treatments. 3, 4 These agents have demonstrated superior CVD event reduction and mortality benefits.

For stage 2 hypertension (≥140/90 mmHg), initiate with two first-line agents, ideally as a single-pill combination. 3 For stage 1 hypertension (130-139/80-89 mmHg), start with a single first-line agent. 3

Beta-blockers (and by extension, alpha-blockers like prazosin) are reserved for compelling indications such as angina, post-MI, heart failure with reduced ejection fraction, or heart rate control. 4

Common Pitfalls

• Starting with doses >1 mg: This dramatically increases syncope risk 1
• Rapid dose escalation: Can precipitate syncopal episodes 1
• Using as monotherapy in 2025: Prazosin lacks the outcomes data of first-line agents
• Ignoring orthostatic symptoms: Hypotension may be exacerbated when combined with beta-blockers 1
• Not warning about priapism: Prolonged erections require immediate medical attention to prevent permanent tissue damage 1

Tolerability Profile

Research shows side effects occur in approximately 27% of patients, most commonly headache, dizziness, and fatigue, with most being mild-to-moderate in severity. 5, 2 Only 5% discontinue due to adverse effects. 2 However, some studies suggest loss of antihypertensive effectiveness during long-term treatment. 6